United States Neurodiagnostics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

1.       Report Overview

1.1.    Report Description

1.2.    Research Methods

1.3.    Research Approaches

2.       Executive Summary

3.       Market Overview

3.1.    Introduction

3.2.    Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.2.4.Challenges

3.3.    PEST-Analysis

3.4.    Porter's Diamond Model for the United States Neurodiagnostics Market

3.5.    IGR-Growth Matrix Analysis

3.6.    Competitive Landscape in the United States Neurodiagnostics Market

4.       United States Neurodiagnostics Market by Technology Type

4.1.    Neuroimaging

4.1.1. Nuclear Medicine Imaging

4.1.2. Electro-encephalography

4.1.3. Magneto-encephalography

4.1.4. Other Neuroimaging Technologies

4.2.    in Vitro Diagnosis

4.2.1. Genetic Testing

4.2.2. Protein Biomarker Assay

4.2.3. Other in Vitro Diagnosis

4.3.    Neuroinformatics

5.       United States Neurodiagnostics Market by Disease Type

5.1.    Migraine

5.2.    Multiple Sclerosis

5.3.    Alzheimer’s Disease

5.4.    Parkinson’s Disease

5.5.    Depression

5.6.    Other Diseases

6.       United States Neurodiagnostics Market by End-user

6.1.    Neurology Centers

6.2.    Diagnostic Laboratories and Imaging Centers

6.3.    Hospitals and Surgical Centers

6.4.    Ambulatory Care Centers

6.5.    Research Laboratories

7.       Company Profiles

7.1.    Company 1

7.2.    Company 2

7.3.    Company 3

7.4.    Company 4

7.5.    Company 5